vs
PATHWARD FINANCIAL, INC.（CASH）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是PATHWARD FINANCIAL, INC.的1.2倍（$321.1M vs $276.3M），PATHWARD FINANCIAL, INC.净利率更高（26.4% vs -18.2%，领先44.6%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
CASH vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.2倍
$276.3M
净利率更高
CASH
高出44.6%
-18.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $321.1M |
| 净利润 | $72.9M | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -18.6% |
| 净利率 | 26.4% | -18.2% |
| 营收同比 | — | 210.8% |
| 净利润同比 | — | 1.4% |
| 每股收益（稀释后） | $3.35 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHMDGL
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $321.1M | ||
| Q3 25 | $186.7M | $287.3M | ||
| Q2 25 | $195.8M | $212.8M | ||
| Q1 25 | $274.8M | $137.3M | ||
| Q4 24 | $182.6M | $103.3M | ||
| Q3 24 | $179.5M | $62.2M | ||
| Q2 24 | $188.6M | — |
净利润CASHMDGL
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $-58.6M | ||
| Q3 25 | $38.8M | $-114.2M | ||
| Q2 25 | $42.1M | $-42.3M | ||
| Q1 25 | $75.0M | $-73.2M | ||
| Q4 24 | $30.0M | $-59.4M | ||
| Q3 24 | $33.5M | $-107.0M | ||
| Q2 24 | $44.9M | — |
毛利率CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | -18.6% | ||
| Q3 25 | 25.9% | -39.7% | ||
| Q2 25 | 24.1% | -22.2% | ||
| Q1 25 | 33.2% | -57.8% | ||
| Q4 24 | 19.8% | -64.8% | ||
| Q3 24 | 20.9% | -187.1% | ||
| Q2 24 | 27.1% | — |
净利率CASHMDGL
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | -18.2% | ||
| Q3 25 | 20.8% | -39.8% | ||
| Q2 25 | 21.5% | -19.9% | ||
| Q1 25 | 27.3% | -53.4% | ||
| Q4 24 | 16.4% | -57.5% | ||
| Q3 24 | 18.7% | -172.0% | ||
| Q2 24 | 23.8% | — |
每股收益（稀释后）CASHMDGL
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $-2.55 | ||
| Q3 25 | $1.69 | $-5.08 | ||
| Q2 25 | $1.81 | $-1.90 | ||
| Q1 25 | $3.14 | $-3.32 | ||
| Q4 24 | $1.23 | $-2.50 | ||
| Q3 24 | $1.34 | $-4.92 | ||
| Q2 24 | $1.78 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $198.7M |
| 总债务越低越好 | $59.5M | $339.9M |
| 股东权益账面价值 | $850.7M | $602.7M |
| 总资产 | $7.1B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资CASHMDGL
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $198.7M | ||
| Q3 25 | $120.6M | $295.7M | ||
| Q2 25 | $258.3M | $186.2M | ||
| Q1 25 | $254.2M | $183.6M | ||
| Q4 24 | $597.4M | $100.0M | ||
| Q3 24 | $158.3M | $232.7M | ||
| Q2 24 | $298.9M | — |
总债务CASHMDGL
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | $339.9M | ||
| Q3 25 | $33.5M | $339.8M | ||
| Q2 25 | $33.4M | $118.4M | ||
| Q1 25 | $33.4M | $118.0M | ||
| Q4 24 | $33.4M | $117.6M | ||
| Q3 24 | $33.4M | $117.1M | ||
| Q2 24 | $33.3M | — |
股东权益CASHMDGL
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $602.7M | ||
| Q3 25 | $858.0M | $625.7M | ||
| Q2 25 | $819.0M | $696.0M | ||
| Q1 25 | $814.7M | $710.6M | ||
| Q4 24 | $758.3M | $754.4M | ||
| Q3 24 | $822.5M | $777.2M | ||
| Q2 24 | $748.4M | — |
总资产CASHMDGL
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $1.3B | ||
| Q3 25 | $7.2B | $1.4B | ||
| Q2 25 | $7.2B | $1.0B | ||
| Q1 25 | $7.0B | $996.6M | ||
| Q4 24 | $7.6B | $1.0B | ||
| Q3 24 | $7.5B | $1.1B | ||
| Q2 24 | $7.5B | — |
负债/权益比CASHMDGL
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | 0.56× | ||
| Q3 25 | 0.04× | 0.54× | ||
| Q2 25 | 0.04× | 0.17× | ||
| Q1 25 | 0.04× | 0.17× | ||
| Q4 24 | 0.04× | 0.16× | ||
| Q3 24 | 0.04× | 0.15× | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-133.8M |
| 自由现金流率自由现金流/营收 | — | -41.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $-133.5M | ||
| Q3 25 | $303.7M | $79.8M | ||
| Q2 25 | $30.4M | $-47.1M | ||
| Q1 25 | $188.3M | $-88.9M | ||
| Q4 24 | $-71.7M | $-104.5M | ||
| Q3 24 | $143.1M | $-67.0M | ||
| Q2 24 | $113.2M | — |
自由现金流CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $-133.8M | ||
| Q3 25 | $300.3M | $79.0M | ||
| Q2 25 | $27.7M | — | ||
| Q1 25 | $184.7M | — | ||
| Q4 24 | $-73.8M | $-104.7M | ||
| Q3 24 | $138.8M | $-67.8M | ||
| Q2 24 | $111.0M | — |
自由现金流率CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | -41.7% | ||
| Q3 25 | 160.9% | 27.5% | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | -40.4% | -101.3% | ||
| Q3 24 | 77.3% | -109.0% | ||
| Q2 24 | 58.8% | — |
资本支出强度CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 0.1% | ||
| Q3 25 | 1.8% | 0.3% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 1.1% | 0.2% | ||
| Q3 24 | 2.4% | 1.3% | ||
| Q2 24 | 1.2% | — |
现金转化率CASHMDGL
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | — | ||
| Q3 25 | 7.83× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | -2.39× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 2.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
